SCHEMBL953874

SCHEMBL953874

I[Zn]c1ccccc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL393949 0.69 ALDH1A1 (0.40) —
SCHEMBL8463116 0.69 — —
SCHEMBL7223845 0.67 — —
Hydrochloric Acid SCHEMBL7924149 0.67 ALDH1A1 (0.38) —
SCHEMBL1141917 0.64 — —
SCHEMBL700612 0.64 — —
SCHEMBL28838098 0.64 — —
SCHEMBL28628681 0.64 — —
SCHEMBL5846438 0.64 — —
Toluene SCHEMBL27775226 0.62 ACHE (0.73) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025242747-A1 MULTI -COMPONENT FORMULATIONS OF ORGANOMETALLIC REAGENTS MERCK PATENT GMBH (DE) 2025-11-27 — — WO claimed
WO-2025242747-A1 MULTI -COMPONENT FORMULATIONS OF ORGANOMETALLIC REAGENTS MERCK PATENT GMBH (DE) 2025-11-27 — — WO disclosed
US-20200179914-A1 METHOD FOR PRODUCING CATALYST POLYPLASTICS CO., LTD. (JP) 2020-06-11 — — US disclosed
US-9466431-B2 Ionic compound and process for production thereof, and electrolytic solution and electrical storage device each utilizing the ionic compound NIPPON SHOKUBAI CO., LTD. (JP) 2016-10-11 — — US disclosed
EP-2667445-A1 IONIC COMPOUND AND PROCESS FOR PRODUCTION THEREOF, AND ELECTROLYTIC SOLUTION AND ELECTRICAL STORAGE DEVICE EACH UTILIZING THE IONIC COMPOUND Nippon Shokubai Co., Ltd. (JP) 2013-11-27 — — EP disclosed
US-8580821-B2 Serotonin transporter (SERT) inhibitors for the treatment of depression and anxiety HOFFMANN-LA ROCHE INC. (US) 2013-11-12 — — US disclosed
US-20130295449-A1 IONIC COMPOUND AND PROCESS FOR PRODUCTION THEREOF, AND ELECTROLYTIC SOLUTION AND ELECTRICAL STORAGE DEVICE EACH UTILIZING THE IONIC COMPOUND NIPPON SHOKUBAI CO., LTD. (JP) 2013-11-07 — — US disclosed
US-20130253201-A1 PROCESS FOR THE PREPARATION OF ENANTIOMERICALLY ENRICHED CYCLIC BETA-ARYL OR HETEROARYL CARBOCYCLIC ACIDS HOFFMANN-LA ROCHE INC. (US) 2013-09-26 — — US disclosed
US-8492437-B2 4-substituted phenoxyphenylacetic acid derivatives ARRAY BIOPHARMA INC. (US) 2013-07-23 — — US disclosed
EP-2057115-B9 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES ARRAY BIOPHARMA INC (US) 2012-12-26 — — EP disclosed
WO-2006102194-A1 IMIDAZOPYRIDAZINE COMPOUNDS ELI LILLY AND COMPANY (US) 2006-09-28 — — WO disclosed
WO-2006045429-A1 HALOGEN SUBSTITUTED BENZODIAZEPINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2006-05-04 — — WO disclosed
US-20060084801-A1 Halogen substituted imidazol[1,5-A][1,2,4]triazolo[1,5-D][1,4]benzodiazepine derivatives F. HOFFMANN-LA ROCHE AG (CH) 2006-04-20 — — US disclosed
US-6897331-B2 Fluorous triphase and other multiphase systems UNIVERSITY OF PITTSBURGH (US) 2005-05-24 — — US disclosed
EP-1404687-A4 FLUOROUS TRIPHASE AND OTHER MULTIPHASE SYSTEMS UNIV PITTSBURGH (US) 2004-10-27 — — EP disclosed
US-6734318-B2 FLUOROUS TRIPHASE AND THER MULTIPHASE SYSTEMS FOR EFFECTING REACTIONS AND/OR SEPARATION UNIVERSITY OF PITTSBURGH 2004-05-11 — — US disclosed
EP-1404687-A2 FLUOROUS TRIPHASE AND OTHER MULTIPHASE SYSTEMS UNIVERSITY OF PITTSBURGH (US) 2004-04-07 — — EP disclosed
US-20030125590-A1 Fluorous triphase and other multiphase systems NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2003-07-03 — — US disclosed
US-20030078444-A1 Fluorous triphase and other multiphase systems NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2003-04-24 — — US disclosed
WO-2002100802-A2 FLUOROUS TRIPHASE AND OTHER MULTIPHASE SYSTEMS UNIVERSITY OF PITTSBURGH (US) 2002-12-19 — — WO disclosed
Send feedback